CRXTQ | Clarus Therapeutics Holdings, Inc. Annual &

Annual Income Statements

(In USD)

Breakdown	2021	2020
Revenue	13.95 Million	6.36 Million
Cost of Revenue	2.72 Million	8.68 Million
Gross Profit	11.23 Million	-2.31 Million
Operating Expenses	50.96 Million	44.85 Million
Selling, General and Administrative Expenses	47.33 Million	42.46 Million
Research and Development Expenses	3.63 Million	2.39 Million
Other Expenses	-	-
Cost and Expenses	53.68 Million	53.54 Million
Operating Income	-39.73 Million	-47.17 Million
Interest Expense	15.89 Million	15.39 Million
Income Tax Expense	15.89 Million	15.39 Million
Earnings before Tax	-40.61 Million	4.34 Million
Net Income	-56.51 Million	-11.04 Million
Earnings Per Share Basic	-8.04	-0.51
Earnings Per Share Diluted	-8.04	-0.51
Weighted Average Shares Outstanding	7.02 Million	21.72 Million
Weighted Average Shares Outstanding (Diluted)	7.02 Million	21.72 Million
Gross Margin	0.81	-0.36
EBIT Margin	-2.84	-7.40
Profit Margin	-4.05	-1.73
EBITDA	-39.7 Million	-47.13 Million
Earnings Before Tax Margin	-2.85	-7.41

Breakdown	2022 Q2	2022 Q1	2021 FY	2021 Q2	2020 FY
Revenue	4.05 Million	4.01 Million	13.95 Million	2.77 Million	6.36 Million
Cost of Revenue	1.16 Million	664 Thousand	2.72 Million	554 Thousand	8.68 Million
Gross Profit	2.89 Million	3.34 Million	11.23 Million	2.22 Million	-2.31 Million
Operating Expenses	13.54 Million	16.89 Million	50.96 Million	15.46 Million	44.85 Million
Selling, General and Administrative Expenses	12.31 Million	16.01 Million	-	14.85 Million	-
Research and Development Expenses	1.22 Million	881 Thousand	-	606 Thousand	-
Other Expenses	-	-	-	-	-
Cost and Expenses	14.7 Million	17.55 Million	53.68 Million	16.01 Million	53.54 Million
Operating Income	-10.65 Million	-13.54 Million	-39.73 Million	-13.23 Million	-47.17 Million
Interest Expense	2.02 Million	1.96 Million	15.89 Million	4.87 Million	15.39 Million
Income Tax Expense	42 Thousand	-642 Thousand	15.89 Million	-	15.39 Million
Earnings before Tax	-10.69 Million	-14.87 Million	-40.61 Million	-18.11 Million	4.34 Million
Net Income	-10.73 Million	-14.22 Million	-56.51 Million	-18.11 Million	-11.04 Million
Earnings Per Share Basic	-0.24	-0.59	-	-0.83	-
Earnings Per Share Diluted	-0.24	-0.59	-	-0.83	-
Weighted Average Shares Outstanding	44.22 Million	24.2 Million	7.02 Million	21.72 Million	21.72 Million
Weighted Average Shares Outstanding (Diluted)	44.22 Million	24.2 Million	7.02 Million	21.72 Million	21.72 Million
Gross Margin	0.71	0.83	0.81	0.80	-0.36
EBIT Margin	-2.63	-3.38	-	-4.76	-
Profit Margin	-2.65	-3.55	-4.05	-6.52	-1.73
EBITDA	-10.64 Million	-13.54 Million	-	-13.23 Million	-
Earnings Before Tax Margin	-2.63	-3.38	-2.85	-4.76	-7.41